Malta - English - Medicines Authority

accord healthcare limited - gemcitabine - concentrate for solution for infusion - gemcitabine 200 mg - antineoplastic agents

Malta - English - Medicines Authority

accord healthcare limited - gemcitabine - concentrate for solution for infusion - gemcitabine 1000 mg - antineoplastic agents

Malta - English - Medicines Authority

accord healthcare limited - gemcitabine - concentrate for solution for infusion - gemcitabine 1500 mg - antineoplastic agents

Malta - English - Medicines Authority

accord healthcare limited - gemcitabine - concentrate for solution for infusion - gemcitabine 2000 mg - antineoplastic agents

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - gemcitabine - concentrate for solution for infusion - 100 milligram(s)/millilitre - pyrimidine analogues; gemcitabine

Malta - English - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - gemcitabine - concentrate for solution for infusion - gemcitabine 200 mg - antineoplastic agents

Malta - English - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - gemcitabine - concentrate for solution for infusion - gemcitabine 1000 mg - antineoplastic agents

Malta - English - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - gemcitabine - concentrate for solution for infusion - gemcitabine 1500 mg - antineoplastic agents

Malta - English - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - gemcitabine - concentrate for solution for infusion - gemcitabine 2000 mg - antineoplastic agents

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - gemcitabine hydrochloride (unii: u347pv74il) (gemcitabine - unii:b76n6sbz8r) - gemcitabine 200 mg in 5.26 ml - gemcitabine for injection in combination with carboplatin is indicated for the treatment of patients with advanced ovarian cancer that has relapsed at least 6 months after completion of platinum-based therapy. gemcitabine for injection in combination with paclitaxel is indicated for the first-line treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing adjuvant chemotherapy, unless anthracyclines were clinically contraindicated. gemcitabine for injection in combination with cisplatin is indicated for the first-line treatment of patients with inoperable, locally advanced (stage iiia or iiib) or metastatic (stage iv) non-small cell lung cancer (nsclc). gemcitabine for injection is indicated as first-line treatment for patients with locally advanced (nonresectable stage ii or stage iii) or metastatic (stage iv) adenocarcinoma of the pancreas. gemcitabine for injection is indicated for patients previously treated with fluorouracil. gemcitabine for injection is contraind